Literature DB >> 1822237

Human alpha 1-3 fucosyltransferases.

B A Macher1, E H Holmes, S J Swiedler, C L Stults, C A Srnka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822237     DOI: 10.1093/glycob/1.6.577

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


× No keyword cloud information.
  7 in total

Review 1.  Occurrence and specificities of alpha 3-fucosyltransferases.

Authors:  T de Vries; D H van den Eijnden
Journal:  Histochem J       Date:  1992-11

Review 2.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Detailed acceptor specificities of human alpha1,3-fucosyltransferases, Fuc-TVII and Fuc-TVI.

Authors:  K Shinoda; E Tanahashi; K Fukunaga; H Ishida; M Kiso
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

4.  Type-1 chain histo-blood group antigens (Le(a), monosialosyl-Le(a), disialosyl-Le(a), Le(b), and H) in normal and malignant human endometrium.

Authors:  V Ravn; U Mandel; B Svenstrup; E Dabelsteen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Expression of type-2 histo-blood group carbohydrate antigens (Le(x), Le(y), and H) in normal and malignant human endometrium.

Authors:  V Ravn; U Mandel; B Svenstrup; E Dabelsteen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.

Authors:  T W De Graaf; M E Van der Stelt; M G Anbergen; W van Dijk
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

7.  α-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation.

Authors:  Dongsheng Li; Hongzhi Sun; Guang Bai; Wei Wang; Miaomiao Liu; Zhiye Bao; Jingjing Li; Hao Liu
Journal:  Int J Mol Med       Date:  2018-08-31       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.